Weekly: Halozyme Therapeutics (HALO: $39.69) decreases 1.7% on below average volume; -69c [1.7%]

Press/Media

PeriodDec 2 2023

Media coverage

1

Media coverage

  • TitleWeekly: Halozyme Therapeutics (HALO: $39.69) decreases 1.7% on below average volume; -69c [1.7%]
    Media name/outletGlobal Round Up - Bullish & Bearish Signals
    Country/TerritoryUnited States
    Date12/2/23
    PersonsMary Daly
View all 1
View less